MFG
RPRX icon

Mendota Financial Group’s Royalty Pharma RPRX Stock Holding History

Mendota Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-771
Closed -$19.7K – 311
2024
Q4 		$19.7K Sell
771
-670
-46% -$17.8K 0.01% 208
2024
Q3 		$40.8K Hold
1,441
– – 0.02% 187
2024
Q2 		$38K Hold
1,441
– – 0.02% 188
2024
Q1 		$43.8K Hold
1,441
– – 0.03% 188
2023
Q4 		$40.5K Hold
1,441
– – 0.03% 211
2023
Q3 		$39.1K Hold
1,441
– – 0.04% 151
2023
Q2 		$44.3K Hold
1,441
– – 0.05% 140
2023
Q1 		$56.1K Hold
1,441
– – 0.06% 137
2022
Q4 		$56.9K Buy
+1,441
New +$60.1K 0.07% 125

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mendota Financial Group's RPRX Position: Q1 2025 in Review

Mendota Financial Group sold out of Royalty Pharma (RPRX) in Q1 2025, closing a stake of 771 shares — an estimated $19.7K sold.

Mendota Financial Group first reported a position in RPRX in Q4 2022 and held it in 9 quarters. The position peaked at $56.9K in Q4 2022. 447 funds tracked by Wall St. Rank hold RPRX as of Q1 2025.

  • Mendota Financial Group reported no remaining Royalty Pharma position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 771 Royalty Pharma shares in Q1 2025, an estimated $19.7K.
  • Mendota Financial Group first reported a position in Royalty Pharma in Q4 2022 and held it in 9 quarters.
  • Mendota Financial Group's Royalty Pharma position peaked at $56.9K in Q4 2022.
  • 447 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.